Arcus Biosciences (RCUS) Other financing activities (2018)

Arcus Biosciences (RCUS) recorded quarterly Other financing activities of $135000.0 in Q1 2018.

Arcus Biosciences (RCUS) Other financing activities (2018) Analysis & Trends

Arcus Biosciences' Other financing activities history runs 1 years deep, the most recent figure standing at $135000.0 for Q1 2018.

In Q1 2018, Other financing activities changed N/A year-over-year to $135000.0; the TTM figure through Dec 2018 stood at $135000.0 (changed N/A YoY), while the FY2018 annual figure was $135000.0, changed N/A from the prior year.
Other financing activities was $135000.0 for Q1 2018 at Arcus Biosciences.
In the past five years, Other financing activities ranged from a high of $135000.0 in Q1 2018 to a low of $135000.0 in Q1 2018.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Arcus Biosciences	3.05 Bn	2.23 Bn	-

Historic Data

Download Data

Date	Value
Mar 31, 2018	135,000.00
Mar 31, 2018	135,000.00